vs
Side-by-side financial comparison of Arcellx, Inc. (ACLX) and SWK Holdings Corp (SWKH). Click either name above to swap in a different company.
SWK Holdings Corp is the larger business by last-quarter revenue ($8.7M vs $8.1M, roughly 1.1× Arcellx, Inc.). On growth, SWK Holdings Corp posted the faster year-over-year revenue change (-29.7% vs -79.3%). SWK Holdings Corp produced more free cash flow last quarter ($26.8M vs $-63.9M). Over the past eight quarters, SWK Holdings Corp's revenue compounded faster (-12.5% CAGR vs -24.6%).
Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.
SWK Holdings Corp is a specialty finance firm focused on the healthcare and life sciences sectors. It provides tailored financing solutions including royalty monetization, structured debt, and asset-backed lending to biotech, pharmaceutical, medical device and diagnostic companies, with its core market centered in North America.
ACLX vs SWKH — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.1M | $8.7M |
| Net Profit | $-62.3M | $-19.4M |
| Gross Margin | — | — |
| Operating Margin | -847.6% | 9.9% |
| Net Margin | -766.0% | — |
| Revenue YoY | -79.3% | -29.7% |
| Net Profit YoY | -765.1% | -430.2% |
| EPS (diluted) | $-1.13 | $-1.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $8.7M | ||
| Q3 25 | — | $10.9M | ||
| Q2 25 | — | $10.1M | ||
| Q1 25 | $8.1M | $11.8M | ||
| Q4 24 | $15.3M | $12.4M | ||
| Q3 24 | $26.0M | $10.4M | ||
| Q2 24 | $27.4M | $10.8M | ||
| Q1 24 | $39.3M | $11.4M |
| Q4 25 | — | $-19.4M | ||
| Q3 25 | — | $8.8M | ||
| Q2 25 | — | $3.5M | ||
| Q1 25 | $-62.3M | $4.5M | ||
| Q4 24 | $-47.1M | $5.9M | ||
| Q3 24 | $-25.9M | $3.5M | ||
| Q2 24 | $-27.2M | $3.7M | ||
| Q1 24 | $-7.2M | $468.0K |
| Q4 25 | — | 9.9% | ||
| Q3 25 | — | 61.3% | ||
| Q2 25 | — | 46.1% | ||
| Q1 25 | -847.6% | 68.6% | ||
| Q4 24 | -348.2% | 44.7% | ||
| Q3 24 | -129.1% | 39.2% | ||
| Q2 24 | -127.8% | 8.3% | ||
| Q1 24 | -40.3% | 9.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | 80.7% | ||
| Q2 25 | — | 35.2% | ||
| Q1 25 | -766.0% | 38.4% | ||
| Q4 24 | -308.4% | 47.5% | ||
| Q3 24 | -99.4% | 33.3% | ||
| Q2 24 | -99.3% | 33.9% | ||
| Q1 24 | -18.3% | 4.1% |
| Q4 25 | — | $-1.59 | ||
| Q3 25 | — | $0.72 | ||
| Q2 25 | — | $0.29 | ||
| Q1 25 | $-1.13 | $0.37 | ||
| Q4 24 | $-0.87 | $0.47 | ||
| Q3 24 | $-0.48 | $0.28 | ||
| Q2 24 | $-0.51 | $0.30 | ||
| Q1 24 | $-0.14 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $543.3M | $42.8M |
| Total DebtLower is stronger | — | $33.0M |
| Stockholders' EquityBook value | $416.9M | $235.1M |
| Total Assets | $648.1M | $272.4M |
| Debt / EquityLower = less leverage | — | 0.14× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $10.2M | ||
| Q2 25 | — | $8.0M | ||
| Q1 25 | $543.3M | $29.8M | ||
| Q4 24 | $587.4M | $5.9M | ||
| Q3 24 | $574.3M | $17.2M | ||
| Q2 24 | $516.7M | $5.5M | ||
| Q1 24 | $573.9M | $5.5M |
| Q4 25 | — | $33.0M | ||
| Q3 25 | — | $33.0M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $33.0M | ||
| Q4 24 | — | $33.0M | ||
| Q3 24 | — | $33.0M | ||
| Q2 24 | — | $33.0M | ||
| Q1 24 | — | $33.0M |
| Q4 25 | — | $235.1M | ||
| Q3 25 | — | $254.2M | ||
| Q2 25 | — | $246.5M | ||
| Q1 25 | $416.9M | $292.7M | ||
| Q4 24 | $454.8M | $288.7M | ||
| Q3 24 | $483.0M | $283.4M | ||
| Q2 24 | $487.2M | $282.8M | ||
| Q1 24 | $496.6M | $279.9M |
| Q4 25 | — | $272.4M | ||
| Q3 25 | — | $289.4M | ||
| Q2 25 | — | $285.7M | ||
| Q1 25 | $648.1M | $331.3M | ||
| Q4 24 | $711.3M | $332.2M | ||
| Q3 24 | $764.9M | $321.3M | ||
| Q2 24 | $734.3M | $321.0M | ||
| Q1 24 | $779.7M | $322.0M |
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.1M | $27.3M |
| Free Cash FlowOCF − Capex | $-63.9M | $26.8M |
| FCF MarginFCF / Revenue | -786.4% | 308.1% |
| Capex IntensityCapex / Revenue | 9.6% | 5.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-122.5M | $43.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $27.3M | ||
| Q3 25 | — | $906.0K | ||
| Q2 25 | — | $7.8M | ||
| Q1 25 | $-63.1M | $8.3M | ||
| Q4 24 | $-46.0M | $23.0M | ||
| Q3 24 | $30.7M | $6.3M | ||
| Q2 24 | $-36.2M | $5.4M | ||
| Q1 24 | $-31.9M | $4.4M |
| Q4 25 | — | $26.8M | ||
| Q3 25 | — | $557.0K | ||
| Q2 25 | — | $7.7M | ||
| Q1 25 | $-63.9M | $8.2M | ||
| Q4 24 | $-47.5M | $22.9M | ||
| Q3 24 | $28.4M | $6.3M | ||
| Q2 24 | $-39.5M | $5.4M | ||
| Q1 24 | $-38.3M | — |
| Q4 25 | — | 308.1% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | 77.0% | ||
| Q1 25 | -786.4% | 69.1% | ||
| Q4 24 | -311.3% | 185.3% | ||
| Q3 24 | 109.2% | 60.4% | ||
| Q2 24 | -144.1% | 49.7% | ||
| Q1 24 | -97.7% | — |
| Q4 25 | — | 5.9% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | 9.6% | 0.8% | ||
| Q4 24 | 9.8% | 1.1% | ||
| Q3 24 | 8.8% | 0.3% | ||
| Q2 24 | 11.7% | 0.2% | ||
| Q1 24 | 16.4% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 3.93× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | 1.47× | ||
| Q1 24 | — | 9.47× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACLX
Segment breakdown not available.
SWKH
| Finance Receivables Segment | $8.4M | 96% |
| Other | $329.0K | 4% |
